AAAAAA
Results:
1-11
|
Results: 11
Authors:
TREAT J
RODRIGUEZ G
MILLER V
LANGER C
BIGELOW R
DEVIN J
LOCKWOOD G
VONROEMELING R
VIALLET J
KRIS M
Citation: J. Treat et al., AN INTEGRATED PHASE I II ANALYSIS OF TIRAZONE(TM) (TIRAPAZAMINE) PLUSCISPLATIN - SAFETY AND EFFICACY IN ADVANCED NONSMALL CELL LUNG-CANCER(NSCLC) PATIENTS/, Annals of oncology, 9, 1998, pp. 665-665
Authors:
DEMETRI GD
KRIS M
WADE J
DEGOS L
CELLA D
Citation: Gd. Demetri et al., QUALITY-OF-LIFE BENEFIT IN CHEMOTHERAPY PATIENTS TREATED WITH EPOETIN-ALPHA IS INDEPENDENT OF DISEASE RESPONSE OR TUMOR TYPE - RESULTS FROMA PROSPECTIVE COMMUNITY ONCOLOGY STUDY, Journal of clinical oncology, 16(10), 1998, pp. 3412-3425
Authors:
BALLATORI E
ROILA F
DEANGELIS V
CICCARESE G
PALLADINO MA
TONATO M
DELFAVERO A
HERRSTEDT J
DICATO M
DUBOIS A
HESKETH P
KRIS M
GRALLA RJ
Citation: E. Ballatori et al., CLINICAL AND METHODOLOGICAL ISSUES IN ANTIEMETIC THERAPY - A WORLDWIDE SURVEY OF EXPERTS OPINIONS, Supportive care in cancer, 5(4), 1997, pp. 269-273
Authors:
ARMSTRONG J
RABEN A
ZELEFSKY M
BURT M
LEIBEL S
BURMAN C
KUTCHER G
HARRISON L
HAHN C
GINSBERG R
RUSCH V
KRIS M
FUKS Z
Citation: J. Armstrong et al., PROMISING SURVIVAL WITH 3-DIMENSIONAL CONFORMAL RADIATION-THERAPY FORNONSMALL CELL LUNG-CANCER, Radiotherapy and oncology, 44(1), 1997, pp. 17-22
Authors:
HESKETH P
NAVARI R
GROTE T
GRALLA R
HAINSWORTH J
KRIS M
ANTHONY L
KHOJASTEH A
TAPAZOGLOU E
BENEDICT C
HAHNE W
Citation: P. Hesketh et al., DOUBLE-BLIND, RANDOMIZED COMPARISON OF THE ANTIEMETIC EFFICACY OF INTRAVENOUS DOLASETRON MESYLATE AND INTRAVENOUS ONDANSETRON IN THE PREVENTION OF ACUTE CISPLATIN-INDUCED EMESIS IN PATIENTS WITH CANCER, Journal of clinical oncology, 14(8), 1996, pp. 2242-2249
Authors:
MASON WP
VERSCHUUREN J
GRAUS F
GRANT S
KRIS M
POSNER JB
DALMAU J
Citation: Wp. Mason et al., ANTI-HU ANTIBODIES IN PATIENTS WITH SMALL-CELL LUNG-CANCER BUT NO PARANEOPLASTIC DISORDER, Annals of neurology, 38(2), 1995, pp. 341-342
Authors:
RUSCH V
KLIMSTRA D
VENKATRAMAN E
OLIVER J
MARTINI N
GRALLA R
KRIS M
DMITROVSKY E
Citation: V. Rusch et al., ABERRANT P53 EXPRESSION PREDICTS CLINICAL RESISTANCE TO CISPLATIN-BASED CHEMOTHERAPY IN LOCALLY ADVANCED NON-SMALL-CELL LUNG-CANCER, Cancer research, 55(21), 1995, pp. 5038-5042
Authors:
KRIS M
JBILO O
BARTELS CF
MASSON P
RHODE S
LOCKRIDGE O
Citation: M. Kris et al., ENDOGENOUS BUTYRYLCHOLINESTERASE IN SV40-TRANSFORMED CELL-LINES - COS-1, COS-7, MRC-5 SV40, AND WI-38 VA13, In vitro cellular & developmental biology. Animal, 30A(10), 1994, pp. 680-689
Authors:
CRAWFORD J
OZER H
STOLLER R
JOHNSON D
LYMAN G
TABBARA I
KRIS M
GROUS J
PICOZZI V
RAUSCH G
SMITH R
GRADISHAR W
YAHANDA A
VINCENT M
STEWART M
GLASPY J
Citation: J. Crawford et al., REDUCTION BY GRANULOCYTE-COLONY-STIMULATING FACTOR OF FEVER AND NEUTROPENIA INDUCED BY CHEMOTHERAPY IN PATIENTS WITH SMALL-CELL LUNG-CANCER, Clinical infectious diseases, 18, 1994, pp. 190000189-190000196
Authors:
ATCHISON DA
KRIS M
Citation: Da. Atchison et M. Kris, OFF-AXIS MEASUREMENTS OF A PLANO DISTANCE POWER PROGRESSIVE ADDITION LENS, Ophthalmic & physiological optics, 13(3), 1993, pp. 322-326
Authors:
SCOTT AM
BASELGA J
DIVGI CR
PFISTER D
KRIS M
ZHANG JJ
DAGHIGHIAN F
CARMICHAEL N
OETTGEN HF
LARSON SM
MENDELSOHN J
Citation: Am. Scott et al., COMPARISON OF PHASE-I TRIALS OF ANTIEPIDERMAL GROWTH-FACTOR RECEPTOR (EGFR) MONOCLONAL-ANTIBODIES (MABS) 528 AND 225 LABELED WITH I-131 ANDIN-111, The Journal of nuclear medicine, 34(5), 1993, pp. 213-213
Risultati:
1-11
|